Viagra may lower the risk of Alzheimer’s disease, according to new research
Study shows a potential link between Viagra use and reduced Alzheimer’s risk
Viagra, the well-known drug used to treat erectile dysfunction, may have an unexpected benefit associated with it. New research suggests that Viagra could potentially lower the risk of Alzheimer’s disease in aging men. The study, based on a massive analysis of nearly 270,000 middle-aged men in Britain, has provided significant insights into the potential effects of Viagra on brain health.
Large-scale study examines the correlation between Viagra use and Alzheimer’s risk
The researchers, from the University College London, utilized electronic medical records to track the men’s health and prescriptions. Each participant was over the age of 40 and had been diagnosed with erectile dysfunction between 2000 and 2017. Over the course of the study, 1,119 men from the cohort were diagnosed with Alzheimer’s disease.
Interestingly, the study found that men prescribed with Viagra or a similar drug had an 18 percent lower risk of developing Alzheimer’s when compared to those who were not given the medication. The protective effect seemed to be even more pronounced in men who used Viagra more frequently, with a 44 percent lower risk among the highest users. It’s worth noting that men with erectile dysfunction are advised to take Viagra only before sexual activity, once a day at most.
Viagra’s origin as a cardiovascular medication may provide insights into its potential benefits
The unexpected link between Viagra and Alzheimer’s risk reduction can be traced back to the drug’s initial development. Pfizer originally formulated Viagra as a cardiovascular medication aimed at treating high blood pressure and chest pain. During clinical trials, patients reported an unforeseen side-effect of prolonged erections, leading to its well-known application in treating erectile dysfunction.
Viagra belongs to a class of drugs called phosphodiesterase Type 5 Inhibitors (PDE-5 drugs) which work by widening blood vessels and increasing blood flow throughout the body. Given the strong connection between heart health and sexual health, the potential effects of these drugs on brain health have been a subject of scientific interest.
Erectile dysfunction, heart health, and the potential impact on brain health
Notably, erectile dysfunction can serve as an early indicator of coronary artery disease. Dysfunction in the vascular system is often a factor in the onset of erectile problems. Furthermore, vascular risk factors have been associated with certain types of dementia, including Alzheimer’s disease.
Research in animals and the associations with Alzheimer’s risk
Studies on animals have indicated that PDE-5 inhibitors, such as Viagra, can contribute to preventing cognitive impairment by enhancing blood flow in the brain. However, the efficacy of these drugs on brain health in humans remains uncertain. Researchers emphasize that the underlying mechanisms observed in animals need to be thoroughly explored in human subjects through comprehensive and specialized clinical trials.
Confounding factors and further research
While the study’s findings suggest a potential link between Viagra and a lower risk of Alzheimer’s disease, a number of confounding variables need to be considered. Factors such as patients’ overall health and lifestyle, including physical and sexual activity, can have an impact on the observed outcomes.
It is crucial to note that the research findings should not be interpreted as an endorsement of Viagra as a preventive measure against Alzheimer’s disease. Further research, including well-designed randomized clinical trials, is necessary to establish conclusive evidence. In the meantime, it is encouraged that men experiencing erectile dysfunction consult their physicians to address both their sexual and cardiovascular health.
Do you have a question about human behavior or neuroscience? Email BrainMatters@washpost.com and we may answer it in a future column.
